IL82298A0 - Anti-dementia agents comprising an adenosine derivative - Google Patents

Anti-dementia agents comprising an adenosine derivative

Info

Publication number
IL82298A0
IL82298A0 IL82298A IL8229887A IL82298A0 IL 82298 A0 IL82298 A0 IL 82298A0 IL 82298 A IL82298 A IL 82298A IL 8229887 A IL8229887 A IL 8229887A IL 82298 A0 IL82298 A0 IL 82298A0
Authority
IL
Israel
Prior art keywords
adenosine derivative
dementia
adenosine
dementia agents
agent
Prior art date
Application number
IL82298A
Other languages
English (en)
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of IL82298A0 publication Critical patent/IL82298A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL82298A 1986-04-25 1987-04-22 Anti-dementia agents comprising an adenosine derivative IL82298A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61094738A JPH0696534B2 (ja) 1986-04-25 1986-04-25 抗痴呆剤

Publications (1)

Publication Number Publication Date
IL82298A0 true IL82298A0 (en) 1987-10-30

Family

ID=14118453

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82298A IL82298A0 (en) 1986-04-25 1987-04-22 Anti-dementia agents comprising an adenosine derivative

Country Status (12)

Country Link
US (1) US5023244A (de)
EP (1) EP0253962B1 (de)
JP (1) JPH0696534B2 (de)
AT (1) ATE87209T1 (de)
AU (1) AU610822B2 (de)
CA (1) CA1287298C (de)
DE (1) DE3784977T2 (de)
DK (1) DK169656B1 (de)
IE (1) IE60886B1 (de)
IL (1) IL82298A0 (de)
PT (1) PT84765B (de)
ZA (1) ZA872879B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
WO1990011080A1 (en) * 1989-03-24 1990-10-04 Daiichi Pharmaceutical Co., Ltd. Drug for improving brain function
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2687678B1 (fr) * 1992-01-31 1995-03-31 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
DK62692D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
DK62592D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
EA200001224A1 (ru) 1998-06-23 2001-08-27 Глаксо Груп Лимитед Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
WO2002004448A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
IT202300022302A1 (it) * 2023-10-24 2025-04-24 Univ Degli Studi Di Roma “La Sapienza” Trattamento di malattie degenerative neuromuscolari

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224438A (en) * 1970-07-14 1980-09-23 Boehringer Mannheim Gmbh Adenosine-5'-carboxylic acid amides
US4029884A (en) * 1971-03-18 1977-06-14 Abbott Laboratories Adenosine-5'-carboxylic acid amides
US3864483A (en) * 1972-03-22 1975-02-04 Abbott Lab Adenosine-5{40 -carboxylic acid amides
US3992531A (en) * 1973-12-26 1976-11-16 Abbott Laboratories 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
LU73052A1 (de) * 1975-07-24 1977-03-24
DE2610985A1 (de) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
LU75374A1 (de) * 1976-07-13 1978-02-08
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use

Also Published As

Publication number Publication date
DK169656B1 (da) 1995-01-09
DE3784977T2 (de) 1993-08-05
ATE87209T1 (de) 1993-04-15
EP0253962A3 (en) 1988-11-30
CA1287298C (en) 1991-08-06
DK209187D0 (da) 1987-04-24
IE871069L (en) 1987-10-25
JPS62252726A (ja) 1987-11-04
PT84765B (pt) 1989-12-29
DE3784977D1 (de) 1993-04-29
US5023244A (en) 1991-06-11
JPH0696534B2 (ja) 1994-11-30
ZA872879B (en) 1987-11-25
IE60886B1 (en) 1994-08-24
AU610822B2 (en) 1991-05-30
DK209187A (da) 1987-10-26
EP0253962B1 (de) 1993-03-24
AU7194687A (en) 1987-10-29
EP0253962A2 (de) 1988-01-27
PT84765A (en) 1987-05-01

Similar Documents

Publication Publication Date Title
ZA872879B (en) Anti-dementia agents
HU9008407D0 (en) Process for the production of purine nucleoside derivatives and medical preparations containing them as active agents
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
HUT48247A (en) Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
HUT51642A (en) Process for producing new 2'-halogenmethylidene, 2'-ethenylidene and 2'-ethinyl cytidine, uridine and guanosine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT49367A (en) Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HUT44131A (en) Herbicide compositions containing pyrazolo-pyrimidine derivatives as active components and process for producing the active components
NZ225906A (en) Aristeromycin/adenosine derivatives and pharmaceutical compositions
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT46839A (en) Herbicide compositions containing phenoxy-phenyl-thiourea-, isothiourea- and carbodiimide derivatives as active components and process for producing the active components
HUT47210A (en) Insecticide compositions and process for producing benzoyl-urea derivatives as active components
HUT55004A (en) Process for producing 1,3-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic compositions containing them as active components
PT84127B (en) Process for the preparation of 1,2-disubstituted piperidines and of herbicide compositions containing the same
HUT42269A (en) Herbicide and fungicide compositions containing carbamoyl-imidazol derivatives as active agents and process for producing carbamoyl-imidazol derivatives
HUT47127A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
NZ233781A (en) (cyclic)phosphonyl-substituted guanine or adenine derivatives and pharmaceutical compositions
HUT48871A (en) Herbicidal compositions and process for producing substituted tetrahydrophtalimide derivatives applicable as active ingredient
WO1989012380A3 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives
HUT49850A (en) Herbicidal compositions comprising pyran derivatives and process for producing the active ingredients
HUT47792A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
HUT43232A (en) Herbicide compositions containing 2-square bracket-bracket-heterocyclic-oxy-bracket closed-phenoxy-square bracket closed-alkanoyl-bracket-halogeno-alkoxy-bracket closed-anilide derivatives as active agents and process for producing the active agents
HUT53616A (en) Herbicides comprising n-phenyl tetrahydroindazole derivatives as active ingredient and process for producing the active ingredients

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired